International Patent: LIPID-BASED OPHTHALMIC FORMULATION FOR TOPICAL USE THAT INCREASES AFLIBERCEPT PENETRATION AND BIOAVAILABILITY IN THE RETINA

GENEVA, July 2 -- CENTRO DE RETINA MÉDICA Y QUIRÚRGICA, S.C. filed a patent application (MX2025/050111) for “LIPID-BASED OPHTHALMIC FORMULATION FOR TOPICAL USE THAT INCREASES AFLIBERCEPT PENETRATION AND BIOAVAILABILITY IN THE RETINA”. With publication no. WO/2026/135443, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 38/17

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....